Self-monitoring of blood glucose in type 2 diabetes. The international SMBG Working Group

GAGLIARDINO JJ; THE INTERNATIONAL SMBG WORKING GROUP

DIABETES CARE

American Diabetes Association

Lugar: Alexandria; Año: 2007 vol. 30 p. 105 - 105

0149-5992

Those involved in type 2 diabetes care must be puzzled by the lack of consensus on self-monitoring of blood glucose (SMBG) (1,2,3), especially in non–insulin-treated patients. This is reflected by wide between-country variation in reimbursement for glucose meters and strips. Balanced evaluation of available data is required; however, further trials are needed to provide robust evidence as to how and in which groups SMBG use is justified. Accordingly, diabetologists and epidemiologists involved in recent SMBG studies in type 2 diabetes met during the 2006 International Diabetes Federation Congress and established an International SMBG Working Group for the exchange of data, analyses, and ideas. Although there was no systematic invitation strategy, 34 individuals from 13 countries have confirmed interest. A cross-sectional Working Group survey generated data from Argentina, Australia, Canada, China, Germany, India, Italy, Netherlands, Norway, Pakistan, Tanzania, the U.K, and the U.S.